Key Highlights

  • HLF shares are trading up 5.12% to $12.11, extending gains from earlier this week.
  • The company announced that CEO Stephan Gratziani will transition to a consultant role effective October 31, with CFO John DeSimone becoming interim CEO on November 1.
  • Herbalife also reaffirmed its third-quarter and full-year 2026 financial guidance, continuing to expect year-over-year net sales growth for both periods.
  • No additional company-specific catalyst was identified in today's session.
  • Full-year 2026 guidance calls for net sales growth of 2.5% to 5.5% and adjusted EBITDA of $670 million to $690 million.

Shares Extend Gains Following This Week's Leadership News

Herbalife (NYSE:HLF) shares are climbing further, continuing to build on gains from earlier this week as investors digest the company's planned leadership transition. Herbalife is a global nutrition company that develops, markets, and distributes wellness products across weight management, targeted nutrition, and energy and fitness categories, operating in more than 90 countries through a direct-selling, Multi-Level Marketing model.

No additional company-specific catalyst was identified in today's session, suggesting the continued gain reflects investors further processing this week's leadership and guidance news.

CEO Transition Set for Later This Year

The company announced that CEO Stephan Gratziani will transition from his role effective October 31, moving into a consultant position focused on strategy and Business development, while also returning his primary focus to his independent distributorship. Chief Financial Officer John DeSimone will serve as interim CEO beginning November 1, bringing nearly 20 years of institutional experience with the company to the role.

Reaffirmed Guidance Reinforces Confidence

Alongside the leadership news, Herbalife reaffirmed its third-quarter and full-year 2026 financial guidance, continuing to expect year-over-year net sales growth for both periods and reaffirming its adjusted EBITDA outlook. Full-year 2026 guidance calls for net sales growth of 2.5% to 5.5% and adjusted EBITDA of $670 million to $690 million, consistent with the outlook the company provided alongside its second-quarter Earnings release.

Investors Weigh a Stable Transition Plan

Herbalife shares are extending their climb as investors appear reassured by the combination of an internal, experienced successor and reaffirmed financial guidance, rather than viewing the leadership change as a source of uncertainty. Continued commentary from incoming interim CEO DeSimone will likely be a key focus for investors in the weeks ahead.